BWAY

$13.73

Market ClosedAs of Mar 17, 8:00 PM UTC

BrainsWay Ltd.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$13.73
Potential Downside
76.4%
Whystock Fair Value$3.24
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of majo...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$538.53M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
85.81
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
11.26%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.24

Recent News

TipRanks
Mar 12, 2026

Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat

The major averages were lower near noon, with the Dow dropping over 400 points as traders weigh shifting oil prices and a key inflation report. Markets are trading cautiously amid volatile energy prices and ongoing geopolitical tensions in the Middle East. Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Oil prices, which spiked

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 11, 2026

BrainsWay Ltd (BRSYF) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances

BrainsWay Ltd (BRSYF) reports a 27% revenue increase and outlines ambitious growth plans for 2026.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 11, 2026

Brainsway Q4 Earnings Call Highlights

Brainsway (NASDAQ:BWAY) reported fourth-quarter and full-year 2025 results that management said closed the year with “strong momentum,” driven by continued growth in its Deep TMS business and a shift toward recurring revenue through long-term leasing agreements. On the company’s earnings call, execu

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 11, 2026

Undiscovered Middle East Gems To Explore In February 2026

As most Gulf markets rally on the back of positive corporate earnings, despite the pressure from fluctuating oil prices, investors are increasingly eyeing opportunities in the Middle East's dynamic economic landscape. With solid fundamentals in non-oil sectors and enhanced market access for foreign investors, identifying stocks with strong growth potential could be key to capitalizing on these favorable conditions.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 6, 2026

Middle East Hidden Gems Including Ayalon Insurance and 2 Promising Stocks

As Middle Eastern markets experience fluctuations due to weak oil prices and geopolitical tensions, investors are keenly observing the region's economic landscape for opportunities amid the challenges. Despite these headwinds, the growth in non-oil sectors and potential monetary easing provide a backdrop where discerning investors might find hidden gems like Ayalon Insurance and two other promising stocks that offer resilience and potential within this dynamic environment.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.